TAKEDA PHARMACEUTICAL CO LTD

TAK · XNYS

CIK 1395064fmd_0PMH94341VM7KDDJNYKRM02K9B制造业 · 医药制剂模板: 标准

覆盖范围: 2015年4月02日至 2025年3月31日，共 31 个期间

利润表 · 年度 · 百万 · JPY
项目	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
营业总收入	1,732,051	1,770,531	2,097,224	3,291,188	3,197,812	3,569,006	4,027,478	4,263,762	4,581,551
营业成本	558,755	495,921	651,729	1,089,764	994,308	1,106,846	1,244,072	1,426,678	1,580,217
毛利润	1,173,296	1,274,610	1,445,495	2,201,424	2,203,504	2,462,160	2,783,406	2,837,084	3,001,334
研发费用	312,303	325,441	368,298	492,381	455,833	526,087	633,325	729,924	730,227
营业利润	155,867	241,789	237,685	100,408	509,269	460,844	490,505	214,075	342,586
利息费用	23,249	31,928	83,289	165,006	248,631	166,607	169,698	219,850	210,065
税前利润	143,346	217,205	127,612	(60,754)	366,235	302,571	375,090	52,791	175,084
所得税费用	27,833	30,497	(7,468)	(105,044)	(9,936)	72,405	58,052	(91,406)	66,941
持续经营净利润	115,513	186,708	135,080	44,290	376,171	230,166	317,038	144,197	108,143
净利润	114,940	186,886	135,192	44,241	376,005	230,059	317,017	144,067	107,928
归属于普通股股东的净利润	114,940	186,886	135,192	44,241	376,005	230,059	317,017	144,067	107,928